Apimeds Pharmaceuticals Valuation
| APUS Stock | 1.46 0.29 16.57% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. Apimeds Pharmaceuticals shows a prevailing Real Value of USD1.56 per share. The current price of the firm is USD1.46. Our model approximates the value of Apimeds Pharmaceuticals from analyzing the firm fundamentals such as Number Of Shares Shorted of 3.22 K, shares outstanding of 11.58 M, and Return On Asset of -4.09 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Apimeds Pharmaceuticals' price fluctuation is abnormally volatile at this time. Calculation of the real value of Apimeds Pharmaceuticals is based on 3 months time horizon. Increasing Apimeds Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Apimeds stock is determined by what a typical buyer is willing to pay for full or partial control of Apimeds Pharmaceuticals US. Since Apimeds Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Apimeds Stock. However, Apimeds Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.46 | Real 1.56 | Hype 1.53 | Naive 1.51 |
The intrinsic value of Apimeds Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Apimeds Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Apimeds Pharmaceuticals US helps investors to forecast how Apimeds stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Apimeds Pharmaceuticals more accurately as focusing exclusively on Apimeds Pharmaceuticals' fundamentals will not take into account other important factors: About Apimeds Pharmaceuticals Valuation
The stock valuation mechanism determines Apimeds Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Apimeds Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Apimeds Pharmaceuticals. We calculate exposure to Apimeds Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Apimeds Pharmaceuticals's related companies.Apimeds Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Apimeds Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 12.7 M | |
| Shares Float | 2 M |
Additional Tools for Apimeds Stock Analysis
When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.